Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Blood Pressure Monitoring, Ambulatory | 5 | 2022 | 244 | 1.930 |
Why?
|
Stroke | 26 | 2024 | 9758 | 1.370 |
Why?
|
Nigeria | 20 | 2024 | 770 | 1.350 |
Why?
|
Hypertension | 12 | 2024 | 8540 | 1.100 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2019 | 851 | 0.830 |
Why?
|
Blood Pressure | 7 | 2022 | 8481 | 0.780 |
Why?
|
Ghana | 12 | 2024 | 315 | 0.700 |
Why?
|
Health Personnel | 5 | 2024 | 3335 | 0.500 |
Why?
|
Prehypertension | 1 | 2015 | 63 | 0.500 |
Why?
|
Antihypertensive Agents | 2 | 2022 | 2024 | 0.430 |
Why?
|
Africa | 7 | 2024 | 709 | 0.390 |
Why?
|
Ventricular Remodeling | 1 | 2019 | 1267 | 0.380 |
Why?
|
Circadian Rhythm | 3 | 2022 | 2576 | 0.370 |
Why?
|
Africa, Western | 6 | 2024 | 159 | 0.360 |
Why?
|
Rheumatic Heart Disease | 3 | 2016 | 163 | 0.350 |
Why?
|
Syncope | 1 | 2013 | 427 | 0.340 |
Why?
|
Echocardiography | 2 | 2019 | 4989 | 0.330 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2019 | 2118 | 0.300 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2022 | 2243 | 0.290 |
Why?
|
Medication Adherence | 1 | 2019 | 2176 | 0.280 |
Why?
|
Ventricular Function, Left | 1 | 2019 | 3879 | 0.270 |
Why?
|
Women's Health | 1 | 2015 | 2065 | 0.250 |
Why?
|
Heart Rate | 1 | 2017 | 4195 | 0.250 |
Why?
|
Prevalence | 7 | 2024 | 15732 | 0.240 |
Why?
|
Electrocardiography | 2 | 2017 | 6377 | 0.230 |
Why?
|
Case-Control Studies | 12 | 2024 | 22176 | 0.220 |
Why?
|
Risk Factors | 19 | 2024 | 74213 | 0.220 |
Why?
|
Environmental Exposure | 2 | 2024 | 4486 | 0.220 |
Why?
|
Blood Glucose | 2 | 2022 | 6391 | 0.200 |
Why?
|
Cerebral Hemorrhage | 3 | 2023 | 2656 | 0.200 |
Why?
|
Pneumonia, Aspiration | 1 | 2023 | 146 | 0.200 |
Why?
|
Middle Aged | 27 | 2024 | 220920 | 0.200 |
Why?
|
Adult | 28 | 2024 | 221203 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2024 | 4016 | 0.190 |
Why?
|
Risk Assessment | 3 | 2021 | 23996 | 0.170 |
Why?
|
Male | 30 | 2024 | 360842 | 0.170 |
Why?
|
Coronary Artery Disease | 2 | 2021 | 6403 | 0.160 |
Why?
|
Cross-Sectional Studies | 9 | 2024 | 26127 | 0.160 |
Why?
|
Qualitative Research | 3 | 2024 | 3023 | 0.150 |
Why?
|
Brain Ischemia | 3 | 2023 | 3049 | 0.150 |
Why?
|
Female | 29 | 2024 | 392686 | 0.150 |
Why?
|
Humans | 46 | 2024 | 761572 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 53 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2017 | 70 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 3 | 2024 | 17904 | 0.140 |
Why?
|
Aged | 17 | 2024 | 169310 | 0.140 |
Why?
|
Disclosure | 1 | 2023 | 748 | 0.140 |
Why?
|
Systole | 1 | 2019 | 936 | 0.140 |
Why?
|
Cost of Illness | 2 | 2018 | 1936 | 0.140 |
Why?
|
Prediabetic State | 1 | 2022 | 545 | 0.140 |
Why?
|
Tobacco Smoke Pollution | 1 | 2022 | 819 | 0.140 |
Why?
|
Cardiovascular Diseases | 4 | 2024 | 15501 | 0.130 |
Why?
|
Rheumatic Fever | 1 | 2016 | 73 | 0.130 |
Why?
|
Multilingualism | 1 | 2015 | 87 | 0.120 |
Why?
|
Prognosis | 3 | 2022 | 29629 | 0.120 |
Why?
|
Phenotype | 3 | 2017 | 16592 | 0.120 |
Why?
|
Rural Population | 1 | 2024 | 2285 | 0.110 |
Why?
|
Sex Factors | 3 | 2017 | 10553 | 0.110 |
Why?
|
Health Priorities | 1 | 2016 | 374 | 0.100 |
Why?
|
Endocarditis | 1 | 2016 | 348 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2018 | 809 | 0.100 |
Why?
|
Disability Evaluation | 1 | 2019 | 1836 | 0.100 |
Why?
|
Waist Circumference | 1 | 2015 | 935 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2021 | 1998 | 0.090 |
Why?
|
Atrial Fibrillation | 2 | 2020 | 5127 | 0.090 |
Why?
|
Air Pollution | 1 | 2024 | 2359 | 0.090 |
Why?
|
Needs Assessment | 1 | 2016 | 1139 | 0.080 |
Why?
|
Anticoagulants | 3 | 2020 | 4812 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2016 | 1475 | 0.080 |
Why?
|
Odds Ratio | 2 | 2022 | 9646 | 0.080 |
Why?
|
Motivation | 1 | 2019 | 2006 | 0.080 |
Why?
|
Acute Coronary Syndrome | 1 | 2021 | 2190 | 0.080 |
Why?
|
Quality-Adjusted Life Years | 1 | 2015 | 1722 | 0.080 |
Why?
|
Primary Prevention | 1 | 2016 | 1186 | 0.080 |
Why?
|
Age Factors | 4 | 2021 | 18398 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1403 | 0.070 |
Why?
|
MicroRNAs | 1 | 2024 | 3816 | 0.070 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2017 | 1310 | 0.070 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 942 | 0.070 |
Why?
|
Morbidity | 2 | 2024 | 1750 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2017 | 3208 | 0.070 |
Why?
|
Registries | 3 | 2021 | 8224 | 0.070 |
Why?
|
Arrhythmias, Cardiac | 1 | 2017 | 2244 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5841 | 0.070 |
Why?
|
Fruit | 2 | 2022 | 1160 | 0.070 |
Why?
|
Survival Rate | 2 | 2020 | 12725 | 0.070 |
Why?
|
Pilot Projects | 2 | 2017 | 8633 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15266 | 0.070 |
Why?
|
Focus Groups | 2 | 2024 | 1413 | 0.070 |
Why?
|
Genomics | 2 | 2024 | 5821 | 0.060 |
Why?
|
Hemorrhage | 1 | 2017 | 3424 | 0.060 |
Why?
|
Adiposity | 1 | 2015 | 1879 | 0.060 |
Why?
|
Heart Failure | 2 | 2018 | 11670 | 0.050 |
Why?
|
Tobacco, Smokeless | 1 | 2024 | 133 | 0.050 |
Why?
|
Retrospective Studies | 3 | 2023 | 80646 | 0.050 |
Why?
|
Adolescent | 6 | 2023 | 88324 | 0.050 |
Why?
|
Brain | 3 | 2023 | 27120 | 0.050 |
Why?
|
Incidence | 2 | 2018 | 21355 | 0.050 |
Why?
|
Infarction | 1 | 2023 | 248 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14607 | 0.050 |
Why?
|
Minerals | 1 | 2022 | 283 | 0.040 |
Why?
|
Recurrence | 1 | 2013 | 8466 | 0.040 |
Why?
|
Independent Living | 1 | 2024 | 579 | 0.040 |
Why?
|
Developing Countries | 3 | 2018 | 2885 | 0.040 |
Why?
|
Young Adult | 4 | 2022 | 59255 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2022 | 58986 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15843 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1702 | 0.040 |
Why?
|
Perception | 1 | 2024 | 1197 | 0.040 |
Why?
|
Clergy | 1 | 2018 | 79 | 0.040 |
Why?
|
Angina, Unstable | 1 | 2021 | 888 | 0.040 |
Why?
|
Time Factors | 1 | 2019 | 39970 | 0.040 |
Why?
|
Body Mass Index | 1 | 2015 | 12954 | 0.040 |
Why?
|
Vegetables | 1 | 2022 | 1195 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20571 | 0.030 |
Why?
|
Urban Population | 1 | 2024 | 2036 | 0.030 |
Why?
|
Penicillin G Benzathine | 1 | 2016 | 25 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2022 | 867 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7827 | 0.030 |
Why?
|
Program Evaluation | 1 | 2024 | 2495 | 0.030 |
Why?
|
Dexamethasone | 1 | 2023 | 1948 | 0.030 |
Why?
|
Parathyroid Hormone | 1 | 2022 | 1803 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 462 | 0.030 |
Why?
|
Asia | 1 | 2016 | 619 | 0.030 |
Why?
|
Epidemiologic Methods | 1 | 2019 | 1336 | 0.030 |
Why?
|
Diet | 2 | 2022 | 8075 | 0.030 |
Why?
|
Cultural Characteristics | 1 | 2015 | 251 | 0.030 |
Why?
|
World Health Organization | 1 | 2020 | 1322 | 0.030 |
Why?
|
Dyslipidemias | 1 | 2021 | 868 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 698 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2395 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36429 | 0.030 |
Why?
|
Particulate Matter | 1 | 2024 | 2605 | 0.030 |
Why?
|
Health Education | 1 | 2018 | 1052 | 0.020 |
Why?
|
Family | 1 | 2023 | 3194 | 0.020 |
Why?
|
Prospective Studies | 3 | 2023 | 54426 | 0.020 |
Why?
|
Penicillins | 1 | 2014 | 402 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2024 | 15936 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20099 | 0.020 |
Why?
|
Air Pollutants | 1 | 2024 | 2896 | 0.020 |
Why?
|
Internationality | 1 | 2015 | 1001 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7213 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2022 | 3188 | 0.020 |
Why?
|
Genetic Testing | 1 | 2023 | 3537 | 0.020 |
Why?
|
Life Style | 1 | 2021 | 3917 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2015 | 1440 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2281 | 0.020 |
Why?
|
Antibiotic Prophylaxis | 1 | 2014 | 637 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3882 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1422 | 0.020 |
Why?
|
Age Distribution | 1 | 2014 | 2880 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1505 | 0.020 |
Why?
|
Aspirin | 1 | 2019 | 3133 | 0.020 |
Why?
|
Heart Valve Diseases | 1 | 2014 | 1027 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 7407 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10508 | 0.020 |
Why?
|
Administration, Oral | 1 | 2014 | 4021 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2018 | 3575 | 0.020 |
Why?
|
Caregivers | 1 | 2018 | 2238 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12690 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39107 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 64684 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10721 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3688 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3627 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 6180 | 0.010 |
Why?
|
Obesity | 1 | 2021 | 12947 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5440 | 0.010 |
Why?
|
Concepts
(168)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_